It is commonly accepted that implant wear particles, generated from the implant device, induce peri-prosthetic osteolysis, a form of chronic inflammatory bone resorption mediated by osteoclasts. Growing evidence suggests that older populations are more susceptible to bone osteolysis. There is a critical need for new strategies to prevent or treat peri-prosthetic osteolysis in the aging society of the U.S. However, the underlying mechanisms for aging-associated osteoclast precursor migration, especially to the peripheral bone lesions, remain elusive. Our earlier studies demonstrate that macrophage migration inhibitory factor (MIF) is chemotactic for blood circulating osteoclast precursors via its cognate receptor CXCR4 in vitro as well as in vivo in a mouse model of particle-induced calvaria osteolysis (Movila et al., 2016. JBMR).Also, the high mobility group protein B1 (HMGB1), recently identified as a central mediator of cellular senescence, significantly enhances MIF secretion from aging rather than young macrophages in vitro. Based on these lines of evidence, we hypothesize that the HMGB1/MIF axis plays a key role in the homing of circulating CXCR4+ OCPs to wear particle-induced osteolytic lesions in the aging population. In this application, Specific Aim 1 is designed to establish the role of HMGB1 in increased MIF production by peri-prosthetic macrophages of aging mice with particle-induced calvaria osteolysis. We will compare the role of HMGB1 and its receptors (TLR family of innate immune receptors and receptor for advanced glycation endproducts [RAGE]) relative to the release of MIF from peri-prosthetic macrophages of young (two month-old) and aged (twenty four month-old) wild type animals, both in vitro and in vivo.
In Specific Aim 2, we will elucidate the molecular mechanisms by which MIF promotes chemotactic migration of circulating OCPs to particle-induced osteolysis lesions in senescent animals. We will establish the molecular mechanism underlying MIF-mediated age-dependent recruitment of OCPs to osteolysis lesions in young vs. aged mice by comparison of the known MIF receptors including, CD74, CXCR2 and CXCR4. For this purpose, real time locomotion of eGFP+CD11b+ OCPs in Csf1r-eGFP-knock-in mice will be monitored using FDA-approved state-of-the-art Cellvizio (Mauna Kea Technologies) intravital endoscopic imaging technology. The proposed research project represents one of the first investigations into the contribution of circulating OCPs to particle-induced bone lytic lesions in senescent organisms. Further, this study will provide a paradigm-shifting framework for the development of novel therapies against wear debris-induced osteolysis lesions in older people, targeting MIF activity.

Public Health Relevance

Progressive generation of implant-derived wear particles is one of the major risk factors in development of peri- prosthetic osteolysis especially in the aging society of the US. Implant-derived wear particles prompt recruitment of osteoclast precursors to the prosthesis-bone interface. To date, the molecular mechanism underlying wear particle-induced bone loss in senescent people remains elusive. The proposed studies will investigate whether circulating osteoclast precursor cells can contribute to a particle-induced bone resorption via high mobility group protein B1/ macrophage migration inhibitory factor (HMGB1/MIF) axis. Once our hypothesis is tested, we will be well placed to develop a novel therapeutic approach for aging-associated peri-prosthetic osteolysis by targeting osteoclast precursor cell activity.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Small Research Grants (R03)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Williams, John
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Nova Southeastern University
Schools of Dentistry/Oral Hygn
Fort Lauderdale
United States
Zip Code
Azuma, Mariane Maffei; Balani, Pooja; Boisvert, Heike et al. (2018) Endogenous acid ceramidase protects epithelial cells from Porphyromonas gingivalis-induced inflammation in vitro. Biochem Biophys Res Commun 495:2383-2389
Ishii, Takenobu; Ruiz-Torruella, Montserrat; Ikeda, Atsushi et al. (2018) OC-STAMP promotes osteoclast fusion for pathogenic bone resorption in periodontitis via up-regulation of permissive fusogen CD9. FASEB J 32:4016-4030
Movila, Alexandru; Kajiya, Mikihito; Wisitrasameewong, Wichaya et al. (2018) Intravital endoscopic technology for real-time monitoring of inflammation caused in experimental periodontitis. J Immunol Methods 457:26-29
Hirschfeld, Josefine; Howait, Mohammed; Movila, Alexandru et al. (2017) Assessment of the involvement of the macrophage migration inhibitory factor-glucocorticoid regulatory dyad in the expression of matrix metalloproteinase-2 during periodontitis. Eur J Oral Sci 125:345-354